STENOCARE Danish cannabis production due to start shortly (Cision)

566

In its September 2018 IPO Memorandum, STENOCARE provided guidance that cultivation of cannabis plants in its Danish production facility was expected during Q1. This milestone is yet to be fulfilled due to a delay in receipt of the plant seedling export certificate from the Canadian authorities. The timing of when the export certificate will be obtained is outside the company’s control.

Ga naar Bron